Neurogene, Inc. Common Stock (NGNE)

Neurogene, Inc. is a biotechnology company that focuses on developing and commercializing therapies for rare genetic neurological disorders. The company leverages gene therapy and other innovative approaches to address unmet medical needs in neurodegenerative and genetic diseases.